Skip to main content

Table 5 Multivariate analyss of overall survival.

From: Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis

  P value Hazard ratio 95% CI
Performance status 0.1 2.098 0.867 - 5.073
Tumor response 0.002 0.43 0.253 - 0.732
Second-line chemotherapy 0.573 0.855 0.495 - 1.476